Found 0 matching trials
A Phase I/II Open-label, Single-arm, Multicenter Clinical Study to Evaluate the Safety and Efficacy of FKC289 in Subjects With Relapsed/Refractory Membranous Nephropathy PHASE1 This Phase I study is designed to evaluate the safety and efficacy of FKC28...
Show More Location
The First Affiliated Hospital of Anhui Medical University
Learn More & Join Trial
Study of NXC-201 CAR-T in Patients With Light Chain (AL) Amyloidosis PHASE1 Open-label Phase 1b Dose Escalation/Dose Expansion study exploring the safe...
Show More Status
Active Not Recruiting
Location
Sutter Health Alta Bates
Learn More & Join Trial
CRISPR Delivered Anti-BCMA Car-T Therapy for Relapsed or Refractory Multiple Myeloma PHASE1 This phase Ib trial tests the safety, side effects and best dose of cluster...
Show More Location
University of California, San Francisco
Learn More & Join Trial
Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT PHASE3 This is a randomised, multicentre, controlled, open-label, Phase III global...
Show More Learn More & Join Trial
Dual Target CAR-T Cell Treatment for Refractory Systemic Lupus Erythematosus (SLE) Patients EARLY_PHASE1 This is an early exploratory phase, single arm, non-randomized, open label,...
Show More Location
Department of Rheumatology, Ren Ji Hospital South Campus, School of Medicine, Shanghai JiaoTong University
Learn More & Join Trial
RD06-05 Universal CD19/BCMA CAR-T for Refractory Pediatric Autoimmune Diseases EARLY_PHASE1 This is a single-arm, open-label, phase I clinical study to evaluate the sa...
Show More Location
Nanjing Children's Hospital
Learn More & Join Trial
A Study of VRD-based Regimen Combined With CART-ASCT-CART2 Treatment in Patients With Primary Plasma Cell Leukemia PHASE2 This is a single-arm, open-label study to evaluate the efficacy and safety ...
Show More Status
Active Not Recruiting
Location
Institute of Hematology and Blood Diseases Hospital Chinese Academy of Medical Sciences
Learn More & Join Trial
Clinical Study on Targeted CD19 or CD19-BCMA CAR-T Therapy for Autoimmune Diseases EARLY_PHASE1 This is an open clinical pharmacological translational Research Study, aimi...
Show More Location
The Third the People's Hospital of Bengbu
Learn More & Join Trial
Assess the Safety and Efficacy of CT0594CP Cells in Relapsed/Refractory Multiple Myeloma or Plasma Cell Leukemia NA This is an open-label, single arm study to evaluate the safety and tolerabi...
Show More Location
Shanghai Tongji Hospital
Learn More & Join Trial
Descartes-08 for Patients With Systemic Lupus Erythematosus PHASE2 This is a Phase II study to evaluate the safety, tolerability and manufactu...
Show More Status
Active Not Recruiting
Location
Profound Research LLC
Learn More & Join Trial